Personalised medicine is revolutionising the way we diagnose and treat rare endocrine tumours. The combined use of increasingly sophisticated clinical tools and precise molecular knowledge is enabling clinicians to better tailor treatments for each individual patient.
This new 3-day meeting from 25 - 27 April 2024, will provide you with essential insight into the latest research, emerging therapies, and innovative diagnostic techniques in the field, so that you can enhance your clinical practice.
Why attend this meeting?
Hear from world-renowned experts: Gain clinical insights from pioneers in the field, who are shaping the future of personalised medicine in rare endocrine tumours.
Join interactive discussions: Be part of lively debates and problem-solving sessions, that will help to advance new therapies and improve patient care.
Forge new collaborations: Expand your professional network by connecting with peers working in the field.
This meeting is aimed at Clinicians, Researchers and Scientists, designed to create a collaborative environment and to accelerate the translation of knowledge between fundamental research into rare endocrine tumours, and the clinical application of novel discoveries to individual patients.
We will cover the main groups of endocrine tumours: Thyroid, Pituitary, Pheochromocytoma and Paraganglioma, Adrenal Cortical, Lung Neuroendocrine, and Gastroenteropancreatic.